DUTCH in 2024: A Year of Profound Change

In this 39-minute podcast, Mark Newman reflects on the DUTCH team’s advancements in hormone education and research in 2023, plus provides insights for what’s to come in the year ahead.

Listen to hear more about the Mastering Functional Hormone Testing course and DUTCH Interpretive Guide that were released in 2023. They also explain the significance of two groundbreaking research studies including the first peer-reviewed study comparing FDA-approved estrogen patches, gels, and creams published in the journal Menopause. This pivotal research underscores the clinical validity and utility of urine metabolite testing in transdermal estrogen replacement therapy.  

As we look ahead to 2024, DUTCH is committed to furthering its mission to profoundly change lives by making it easier for providers and patients to access reports and hormone education. Be the first to hear about a new educational course on Menopausal hormone therapy, designed to help providers navigate the complexities of monitoring and dosing HRT.